Norman David Eansor, President-Protein Sciences at BIO-TECHNE Corp (TECH), sold 45,766 shares at $381.52 ($17.4M) on 2021-02-05, disclosed to the SEC on 2021-02-09.
Open-market sale of $17.4M TECH by President-Protein Sciences. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $378.29 | 6,000 | $2.3M | 13.0% |
| 2 | $379.62 | 4,500 | $1.7M | 9.8% |
| 3 | $380.50 | 12,833 | $4.9M | 28.0% |
| 4 | $380.50 | 12,833 | $4.9M | 28.0% |
| 5 | $381.52 | 2,900 | $1.1M | 6.4% |
| 6 | $382.60 | 3,700 |
| $1.4M |
| 8.1% |
| 7 | $384.15 | 1,900 | $730K | 4.2% |
| 8 | $385.59 | 1,100 | $424K | 2.4% |
| Total | $380.63 avg | 45,766 | $17.4M | 100% |
| Filing → |
| TECH | SELL | 2021-09-02 | $1.5M | — | Filing → |
| TECH | SELL | 2020-06-01 | $4.1M | — | Filing → |
| TECH | SELL | 2020-05-26 | $12.4M | — | Filing → |